Comparison of platelet rich plasma and triamcinolone in patient of osteoarthritis of knee for pain relief.
Not Applicable
- Conditions
- Health Condition 1: M179- Osteoarthritis of knee, unspecifiedHealth Condition 2: M179- Osteoarthritis of knee, unspecifiedHealth Condition 3: M171- Unilateral primary osteoarthritisof kneeHealth Condition 4: M171- Unilateral primary osteoarthritisof knee
- Registration Number
- CTRI/2022/04/042058
- Lead Sponsor
- Government medical college bhavnagr
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Grades I , II, III Knee OA according to criteria of American college of rheumatology
2)History of chronic pain > 3 month duration
3)Swelling of knee > 4 month
4)X-ray diagnosis ( Kellgren Lawrence 1 and 2)
Exclusion Criteria
1)Knee joint deformities
2)Acute infection
3)H/o knee surgery
4)H/o diabetes mellitus
5)H/o rheumatoid arthritis, gout
H/o severe cardio vascular disorder, 5)haematological disorders, renal disorder
Immunodeficiency
6)Patients taking anticoagulants
7)Patients with haemoglobin values of <10 and platelets values of <1,50,000/mm3
8)H/o vasovagal shock
9)Pregnant and lactating females
10)H/o corticosteroid consumption within last 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)To compare pain decrement by VAS Score ( Visual analogue score). <br/ ><br>T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week) <br/ ><br>3)To compare prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group.Timepoint: 1)To compare pain decrement by VAS Score ( Visual analogue score). <br/ ><br>T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week) <br/ ><br>3)To compare prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group.
- Secondary Outcome Measures
Name Time Method 1)To compare analgesic requirement during the study period between two group. <br/ ><br>2)To compare need of surgical intervention require during study period Between two group. <br/ ><br>Timepoint: 3 MONTHS